Jilin Maifeng Biological Pharmaceutical Co., Ltd.

14 days after the full course of the test vaccine, the antibody conversion rate of the test vaccine group reached 100%; the antibody conversion rate of the test vaccine was non-inferior to that of the control vaccine. The geometric mean concentration (GMC) of rabies virus neutralizing antibodies in the test vaccine group and the control vaccine group was compared 14 days after the first dose and 14 days after the full course of vaccination; all subjects were observed in detail for adverse events that occurred within 30 days after the first dose and within 6 months after the full course of vaccination.